New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents.

Infect Drug Resist · 2010 · PMC3108733 · PMID 21694902

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Phase III trials have just been completed for two protease inhibitors (TPR and BPR) and have shown a highly significant increase in viral eradication rates when given in association with SOC treatment.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.